INFECTION

Cepheid's bacteria infection test gets FDA OK

The U.S. Food and Drug Administration (FDA) has approved molecular diagnostics company Cepheid (NASDAQ: CPHD)'s test designed to detect the toxin associated with a common bacterial infection that can cause diarrhea and other serious intestinal conditions and death in severe cases.

FDA OK's device to treat brain aneurysms

The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland
The U.S. Food and Drug Administration (FDA) cleared a new device, manufactured by California-based ev3, to treat brain aneurysms without performing open surgery.
IBTimes Logo

Cubist Pharma Shares Hit New High

Shares of Cubist Pharmaceuticals Inc. (CBST) touched a new 52-week high of $30.02 on Wednesday morning. Optimer Pharmaceuticals Inc. (OPTR) said it has entered an exclusive two-year co-promotion agreement with Cubist to market Dificid in the U.S.
More news
Vertex Pharmaceuticals

Vertex Pharma Shares Hit New High Again

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) reported positive interim results on March 2 from a Phase 2 two-part study of 'telaprevir' combination therapy for treatment of hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection. The shares of the drugmaker touched a new 52-week high of $51.10 on Friday.
Vertex Pharmaceuticals

Vertex Pharma stock hits new high again on positive study results

Shares of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) touched a new 52-week high of $50.83 on Thursday. The company announced positive interim results on Wednesday from a Phase 2 two-part study of 'telaprevir' combination therapy for treatment of hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection.
Vertex Pharmaceuticals

Vertex Pharma Stock Hits New High On Positive Hepatitis C-HIV Drug Study

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) announced positive interim results on Wednesday from a Phase 2 two-part study of 'telaprevir' combination therapy for treatment of hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection. The shares of the drugmaker touched a new 52-week high of $47.82 on Wednesday.
IBTimes Logo

S.Africa customs shake-up to hit neighbours

The Southern Africa Customs Union (SACU) is considering a major overhaul of revenue-sharing that will see South Africa keeping a far bigger slice of pooled customs receipts, according to a policy document.
Nelson Mandela

Mandela recovering well, visitor rush a concern

Former South African President Nelson Mandela is recovering well from a respiratory infection that led to his hospitalisation last week but doctors are worried there may be too many people trying to visit him.

Years-old Conficker Worm Still A Threat

A computer worm that first appeared more than two years ago is still a threat, even though security experts were successful in mitigating possible damage.

Zsa Zsa Gabor to Sell Bel Air Mansion

Zsa Zsa Gabor and her husband Frederic Prinz von Anhalt are planning to sell their Bel Air, Calif., mansion for about $28 million. An option of lease and buy is also available, said John Blanchette, a publicist for Gabor.

Scientists make chickens that don't spread bird flu

British scientists have developed genetically modified (GM) chickens that cannot transmit bird flu infections -- a step that in future could reduce the risk of avian flu spreading and causing deadly epidemics in humans.
How Safe Is Our Food?

How Safe Is Our Food?

Foodborne disease, commonly called food poisoning, is any illness resulting from the consumption of contaminated food. Salmonella was the leading cause of foodborne disease in the U.S., according to a study.
Revised plan by WHO to eliminate TB.

WHO backs 100 minutes TB test

The World Health Organization has endorsed a new, rapid tuberculosis (TB) test that can diagnose the killer disease within two hours.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.